School of Medicine

WashU Medicine researchers engineered a new cellular immunotherapy that turns brain cells called astrocytes into super cleaners, efficiently removing amyloid beta plaques from the brains of mice.

During WashU Medicine’s 2026 Martin Luther King Jr. Commemoration Week, 22 faculty, staff and students were recognized with Drum Major Awards for embodying King’s work and words.

The annual Assistive Tech Make-a-Thon brings together WashU OT and engineering students to enhance the lives of St. Louisans who have disabilities.

WashU Medicine researchers have shown in a new study that GLP-1 medications, typically used for diabetes and weight loss, may be effective at treating and preventing substance use disorders, from alcohol to cigarettes to opioids.

Four WashU researchers have been named senior members of the National Academy of Inventors: Rajan Chakrabarty, Vijay Ramani, Christina Stallings and Zhude Tu.

The 2026-28 Carol B. and Jerome T. Loeb Teaching Fellows at WashU Medicine have been named. They are Salim Chahin, MD (left), an associate professor of neurology, and Ram K. Rohatgi, MD, an assistant professor of pediatrics and of radiology.

A mobile app developed by WashU Medicine researchers is effective at helping patients with substance use disorder who are in unstable housing situations take steps toward recovery, a new study found.

The master’s program in biomedical data science and artificial intelligence is one of few such programs in the U.S. It offers a flexible curriculum, part-time enrollment and evening classes to accommodate working students.

A new study from researchers at WashU Medicine shows that chronic organ rejection may be triggered by the disruption of lymphatic vessels from the donor organ rather than an attack by the patient’s immune system.

A new study by WashU Medicine researchers in mice sheds light on the brain’s response to a high-fat and very low-carb diet, which has long been known to help treat some people with epilepsy.